Balmer Lawrie & Company Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: May 15, 2025, 10:06 pm

Market Cap	3,876 Cr.
Current Price	227
High / Low	320/147
Stock P/E	15.0
Book Value	104
Dividend Yield	3.75 %
ROCE	15.6 %
ROE	14.7 %
Face Value	10.0
PEG Ratio	0.88

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Balmer Lawrie & Company Ltd

Competitors of Balmer Lawrie & Company Ltd

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
NESCO Ltd	6,786 Cr.	963	1,082/780	17.3	345	0.62 %	22.4 %	17.0 %	2.00
DCM Shriram Ltd	16,255 Cr.	1,042	1,371/885	26.9	449	0.63 %	11.7 %	8.93 %	2.00
Balmer Lawrie & Company Ltd	3,876 Cr.	227	320/147	15.0	104	3.75 %	15.6 %	14.7 %	10.0
3M India Ltd	33,336 Cr.	29,565	41,000/25,714	54.5	1,906	0.54 %	40.5 %	30.5 %	10.0
Industry Average	15,063.25 Cr	7,949.25		28.43	701.00	1.39%	22.55%	17.78%	6.00

All Competitor Stocks of Balmer Lawrie & Company Ltd

Quarterly Result

Metric	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Sales	505	575	648	551	514	608	592	586	585	577	638	639	630
Expenses	469	511	587	513	464	556	528	511	511	485	574	569	546
Operating Profit	36	64	61	39	50	52	65	75	74	91	64	70	84
OPM %	7%	11%	9%	7%	10%	9%	11%	13%	13%	16%	10%	11%	13%
Other Income	5	15	8	8	3	17	10	13	11	18	12	11	9
Interest	4	3	5	4	5	5	6	5	5	6	6	5	9
Depreciation	14	14	14	14	14	14	15	14	14	15	14	14	15
Profit before tax	23	62	51	29	34	51	54	69	64	88	56	62	68
Tax %	23%	43%	22%	37%	29%	51%	22%	31%	24%	31%	20%	30%	29%
Net Profit	26	46	55	34	35	43	56	63	66	73	63	61	62
EPS in Rs	1.59	2.76	3.28	2.05	2.11	2.61	3.35	3.73	3.90	4.31	3.73	3.66	3.77

Last Updated: February 28, 2025, 8:28 pm

Below is a detailed analysis of the quarterly data for Balmer Lawrie & Company Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:

For Sales, as of Dec 2024, the value is 630.00 Cr.. The value appears to be declining and may need further review. It has decreased from 639.00 Cr. (Sep 2024) to 630.00 Cr., marking a decrease of 9.00 Cr..
For Expenses, as of Dec 2024, the value is 546.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 569.00 Cr. (Sep 2024) to 546.00 Cr., marking a decrease of 23.00 Cr..
For Operating Profit, as of Dec 2024, the value is 84.00 Cr.. The value appears strong and on an upward trend. It has increased from 70.00 Cr. (Sep 2024) to 84.00 Cr., marking an increase of 14.00 Cr..
For OPM %, as of Dec 2024, the value is 13.00%. The value appears strong and on an upward trend. It has increased from 11.00% (Sep 2024) to 13.00%, marking an increase of 2.00%.
For Other Income, as of Dec 2024, the value is 9.00 Cr.. The value appears to be declining and may need further review. It has decreased from 11.00 Cr. (Sep 2024) to 9.00 Cr., marking a decrease of 2.00 Cr..
For Interest, as of Dec 2024, the value is 9.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 5.00 Cr. (Sep 2024) to 9.00 Cr., marking an increase of 4.00 Cr..
For Depreciation, as of Dec 2024, the value is 15.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 14.00 Cr. (Sep 2024) to 15.00 Cr., marking an increase of 1.00 Cr..
For Profit before tax, as of Dec 2024, the value is 68.00 Cr.. The value appears strong and on an upward trend. It has increased from 62.00 Cr. (Sep 2024) to 68.00 Cr., marking an increase of 6.00 Cr..
For Tax %, as of Dec 2024, the value is 29.00%. The value appears to be improving (decreasing) as expected. It has decreased from 30.00% (Sep 2024) to 29.00%, marking a decrease of 1.00%.
For Net Profit, as of Dec 2024, the value is 62.00 Cr.. The value appears strong and on an upward trend. It has increased from 61.00 Cr. (Sep 2024) to 62.00 Cr., marking an increase of 1.00 Cr..
For EPS in Rs, as of Dec 2024, the value is 3.77. The value appears strong and on an upward trend. It has increased from 3.66 (Sep 2024) to 3.77, marking an increase of 0.11.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: March 7, 2025, 9:07 pm

Metric	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM
Sales	3,013	3,120	3,254	1,591	1,702	1,720	1,772	1,532	1,526	2,051	2,312	2,328	2,484
Expenses	2,779	2,908	3,031	1,386	1,492	1,502	1,539	1,342	1,385	1,882	2,109	2,023	2,175
Operating Profit	234	212	223	205	211	219	233	189	141	169	202	305	309
OPM %	8%	7%	7%	13%	12%	13%	13%	12%	9%	8%	9%	13%	12%
Other Income	55	70	64	63	56	51	51	51	49	37	37	51	50
Interest	23	24	23	5	5	4	7	15	12	14	18	22	26
Depreciation	38	35	46	24	26	27	30	52	55	57	57	59	60
Profit before tax	229	222	218	240	236	238	247	173	123	136	164	274	274
Tax %	27%	30%	30%	32%	34%	31%	35%	32%	33%	35%	35%	27%
Net Profit	167	156	152	164	155	165	197	155	115	134	168	257	259
EPS in Rs	9.79	9.09	8.89	9.58	9.05	9.66	11.65	9.43	7.04	8.05	10.05	15.29	15.47
Dividend Payout %	30%	27%	34%	35%	52%	69%	63%	80%	85%	81%	75%	56%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2013-2014	2014-2015	2015-2016	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024
YoY Net Profit Growth (%)	-6.59%	-2.56%	7.89%	-5.49%	6.45%	19.39%	-21.32%	-25.81%	16.52%	25.37%	52.98%
Change in YoY Net Profit Growth (%)	0.00%	4.02%	10.46%	-13.38%	11.94%	12.94%	-40.71%	-4.49%	42.33%	8.85%	27.60%

Balmer Lawrie & Company Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2013-2014 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:	-3%
5 Years:	10%
3 Years:	7%
TTM:	8%

Compounded Profit Growth
10 Years:	5%
5 Years:	11%
3 Years:	25%
TTM:	1%

Stock Price CAGR
10 Years:	8%
5 Years:	17%
3 Years:	23%
1 Year:	-28%

Return on Equity
10 Years:	12%
5 Years:	11%
3 Years:	13%
Last Year:	14%

Last Updated: Unknown

Balance Sheet

Last Updated: November 15, 2024, 1:37 am

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Sep 2024
Equity Capital	16	28	28	28	114	114	114	171	171	171	171	171	171
Reserves	847	953	1,015	1,210	1,247	1,342	1,406	1,383	1,371	1,416	1,510	1,650	1,613
Borrowings	196	175	197	0	0	15	81	120	125	122	121	113	124
Other Liabilities	668	724	670	559	669	720	682	660	712	736	860	939	996
Total Liabilities	1,726	1,880	1,911	1,798	2,030	2,191	2,282	2,334	2,379	2,445	2,662	2,873	2,904
Fixed Assets	452	464	577	393	397	410	568	770	767	767	760	751	730
CWIP	12	77	12	11	63	138	117	24	32	11	28	52	64
Investments	0	0	0	248	271	293	325	375	386	436	518	565	597
Other Assets	1,262	1,339	1,322	1,146	1,299	1,350	1,272	1,165	1,194	1,231	1,356	1,505	1,513
Total Assets	1,726	1,880	1,911	1,798	2,030	2,191	2,282	2,334	2,379	2,445	2,662	2,873	2,904

Below is a detailed analysis of the balance sheet data for Balmer Lawrie & Company Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

For Equity Capital, as of Sep 2024, the value is 171.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 171.00 Cr..
For Reserves, as of Sep 2024, the value is 1,613.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,650.00 Cr. (Mar 2024) to 1,613.00 Cr., marking a decrease of 37.00 Cr..
For Borrowings, as of Sep 2024, the value is 124.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 113.00 Cr. (Mar 2024) to 124.00 Cr., marking an increase of 11.00 Cr..
For Other Liabilities, as of Sep 2024, the value is 996.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 939.00 Cr. (Mar 2024) to 996.00 Cr., marking an increase of 57.00 Cr..
For Total Liabilities, as of Sep 2024, the value is 2,904.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,873.00 Cr. (Mar 2024) to 2,904.00 Cr., marking an increase of 31.00 Cr..
For Fixed Assets, as of Sep 2024, the value is 730.00 Cr.. The value appears to be declining and may need further review. It has decreased from 751.00 Cr. (Mar 2024) to 730.00 Cr., marking a decrease of 21.00 Cr..
For CWIP, as of Sep 2024, the value is 64.00 Cr.. The value appears strong and on an upward trend. It has increased from 52.00 Cr. (Mar 2024) to 64.00 Cr., marking an increase of 12.00 Cr..
For Investments, as of Sep 2024, the value is 597.00 Cr.. The value appears strong and on an upward trend. It has increased from 565.00 Cr. (Mar 2024) to 597.00 Cr., marking an increase of 32.00 Cr..
For Other Assets, as of Sep 2024, the value is 1,513.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,505.00 Cr. (Mar 2024) to 1,513.00 Cr., marking an increase of 8.00 Cr..
For Total Assets, as of Sep 2024, the value is 2,904.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,873.00 Cr. (Mar 2024) to 2,904.00 Cr., marking an increase of 31.00 Cr..

Notably, the Reserves (1,613.00 Cr.) exceed the Borrowings (124.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity +	167	201	150	181	129	194	189	244	2	208	274	156
Cash from Investing Activity +	-76	-42	-71	-117	-19	-137	-60	-80	137	-48	-105	23
Cash from Financing Activity +	-131	-143	-66	-73	-86	-78	-162	-149	-127	-147	-178	-189
Net Cash Flow	-40	16	13	-9	24	-21	-34	15	12	12	-9	-10

Free Cash Flow

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Free Cash Flow	38.00	37.00	26.00	205.00	211.00	204.00	152.00	69.00	16.00	47.00	81.00	192.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	54	62	53	53	60	57	57	65	69	56	57	67
Inventory Days	45	48	48	77	51	46	47	57	59	51	46	46
Days Payable	48	53	44	144	104	108	96	88	100	69	68	74
Cash Conversion Cycle	51	57	56	-14	8	-4	8	35	28	38	35	38
Working Capital Days	24	31	33	-9	30	40	44	52	33	51	41	43
ROCE %	25%	22%	20%	20%	18%	17%	16%	11%	8%	8%	10%	16%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
FIIs	1.63%	1.61%	1.62%	1.31%	1.20%	1.95%	1.82%	2.12%	2.71%	3.07%	3.22%	3.58%
DIIs	2.50%	2.49%	2.50%	2.50%	2.47%	2.45%	2.48%	2.21%	2.09%	1.93%	1.90%	1.89%
Government	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%
Public	95.84%	95.87%	95.84%	96.16%	96.29%	95.56%	95.66%	95.63%	95.17%	94.98%	94.85%	94.50%
No. of Shareholders	97,916	96,775	96,645	93,740	91,600	87,027	87,348	89,289	93,411	1,01,912	1,06,173	1,07,445

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund Name	No of Shares	AUM (%)	Amount Invested (Cr)	Previous Number of Shares	Previous Date	Percentage Change
Motilal Oswal Nifty Microcap 250 Index Fund	92,092	0.26	2.25	92,092	2025-04-22 17:25:41	0%
Groww Nifty Total Market Index Fund	394	0.01	0.01	394	2025-04-22 17:25:41	0%

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
FaceValue	10.00	10.00	10.00	10.00	10.00
Basic EPS (Rs.)	15.30	10.05	8.07	7.04	9.43
Diluted EPS (Rs.)	15.30	10.05	8.07	7.04	9.43
Cash EPS (Rs.)	15.11	9.57	8.49	8.05	9.94
Book Value[Excl.RevalReserv]/Share (Rs.)	108.06	100.11	94.94	92.46	93.45
Book Value[Incl.RevalReserv]/Share (Rs.)	108.06	100.11	94.94	92.46	93.45
Revenue From Operations / Share (Rs.)	136.79	135.76	120.19	89.41	89.73
PBDIT / Share (Rs.)	20.80	13.98	12.06	11.09	14.04
PBIT / Share (Rs.)	17.34	10.66	8.79	7.88	11.01
PBT / Share (Rs.)	16.05	9.61	8.00	7.18	10.14
Net Profit / Share (Rs.)	11.65	6.25	5.23	4.83	6.91
NP After MI And SOA / Share (Rs.)	15.30	10.05	7.88	6.74	9.05
PBDIT Margin (%)	15.20	10.29	10.03	12.40	15.64
PBIT Margin (%)	12.67	7.85	7.31	8.80	12.27
PBT Margin (%)	11.73	7.07	6.65	8.03	11.30
Net Profit Margin (%)	8.52	4.60	4.35	5.40	7.70
NP After MI And SOA Margin (%)	11.18	7.40	6.55	7.54	10.08
Return on Networth / Equity (%)	14.36	10.22	8.48	7.47	9.96
Return on Capital Employeed (%)	13.71	9.02	7.83	7.27	10.22
Return On Assets (%)	9.10	6.45	5.50	4.84	6.62
Long Term Debt / Equity (X)	0.03	0.04	0.05	0.06	0.06
Total Debt / Equity (X)	0.04	0.05	0.05	0.06	0.06
Asset Turnover Ratio (%)	0.84	0.90	0.94	0.71	0.73
Current Ratio (X)	2.08	2.09	2.31	2.24	2.33
Quick Ratio (X)	1.81	1.77	1.93	1.94	2.04
Inventory Turnover Ratio (X)	5.07	7.88	5.34	3.90	4.18
Dividend Payout Ratio (NP) (%)	49.03	64.67	76.14	111.23	81.00
Dividend Payout Ratio (CP) (%)	39.98	48.61	53.84	75.30	60.71
Earning Retention Ratio (%)	50.97	35.33	23.86	-11.23	19.00
Cash Earning Retention Ratio (%)	60.02	51.39	46.16	24.70	39.29
Interest Coverage Ratio (X)	16.13	13.33	15.17	15.92	16.14
Interest Coverage Ratio (Post Tax) (X)	10.04	6.96	7.58	7.93	8.95
Enterprise Value (Cr.)	3661.98	1567.62	1642.42	1805.18	1045.79
EV / Net Operating Revenue (X)	1.57	0.67	0.79	1.18	0.68
EV / EBITDA (X)	10.30	6.56	7.97	9.51	4.36
MarketCap / Net Operating Revenue (X)	1.75	0.81	0.93	1.44	0.88
Retention Ratios (%)	50.96	35.32	23.85	-11.23	18.99
Price / BV (X)	2.24	1.13	1.21	1.43	0.87
Price / Net Operating Revenue (X)	1.75	0.81	0.93	1.44	0.88
EarningsYield	0.06	0.09	0.06	0.05	0.11

After reviewing the key financial ratios for Balmer Lawrie & Company Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
For Basic EPS (Rs.), as of Mar 24, the value is 15.30. This value is within the healthy range. It has increased from 10.05 (Mar 23) to 15.30, marking an increase of 5.25.
For Diluted EPS (Rs.), as of Mar 24, the value is 15.30. This value is within the healthy range. It has increased from 10.05 (Mar 23) to 15.30, marking an increase of 5.25.
For Cash EPS (Rs.), as of Mar 24, the value is 15.11. This value is within the healthy range. It has increased from 9.57 (Mar 23) to 15.11, marking an increase of 5.54.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 108.06. It has increased from 100.11 (Mar 23) to 108.06, marking an increase of 7.95.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 108.06. It has increased from 100.11 (Mar 23) to 108.06, marking an increase of 7.95.
For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 136.79. It has increased from 135.76 (Mar 23) to 136.79, marking an increase of 1.03.
For PBDIT / Share (Rs.), as of Mar 24, the value is 20.80. This value is within the healthy range. It has increased from 13.98 (Mar 23) to 20.80, marking an increase of 6.82.
For PBIT / Share (Rs.), as of Mar 24, the value is 17.34. This value is within the healthy range. It has increased from 10.66 (Mar 23) to 17.34, marking an increase of 6.68.
For PBT / Share (Rs.), as of Mar 24, the value is 16.05. This value is within the healthy range. It has increased from 9.61 (Mar 23) to 16.05, marking an increase of 6.44.
For Net Profit / Share (Rs.), as of Mar 24, the value is 11.65. This value is within the healthy range. It has increased from 6.25 (Mar 23) to 11.65, marking an increase of 5.40.
For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 15.30. This value is within the healthy range. It has increased from 10.05 (Mar 23) to 15.30, marking an increase of 5.25.
For PBDIT Margin (%), as of Mar 24, the value is 15.20. This value is within the healthy range. It has increased from 10.29 (Mar 23) to 15.20, marking an increase of 4.91.
For PBIT Margin (%), as of Mar 24, the value is 12.67. This value is within the healthy range. It has increased from 7.85 (Mar 23) to 12.67, marking an increase of 4.82.
For PBT Margin (%), as of Mar 24, the value is 11.73. This value is within the healthy range. It has increased from 7.07 (Mar 23) to 11.73, marking an increase of 4.66.
For Net Profit Margin (%), as of Mar 24, the value is 8.52. This value is within the healthy range. It has increased from 4.60 (Mar 23) to 8.52, marking an increase of 3.92.
For NP After MI And SOA Margin (%), as of Mar 24, the value is 11.18. This value is within the healthy range. It has increased from 7.40 (Mar 23) to 11.18, marking an increase of 3.78.
For Return on Networth / Equity (%), as of Mar 24, the value is 14.36. This value is below the healthy minimum of 15. It has increased from 10.22 (Mar 23) to 14.36, marking an increase of 4.14.
For Return on Capital Employeed (%), as of Mar 24, the value is 13.71. This value is within the healthy range. It has increased from 9.02 (Mar 23) to 13.71, marking an increase of 4.69.
For Return On Assets (%), as of Mar 24, the value is 9.10. This value is within the healthy range. It has increased from 6.45 (Mar 23) to 9.10, marking an increase of 2.65.
For Long Term Debt / Equity (X), as of Mar 24, the value is 0.03. This value is below the healthy minimum of 0.2. It has decreased from 0.04 (Mar 23) to 0.03, marking a decrease of 0.01.
For Total Debt / Equity (X), as of Mar 24, the value is 0.04. This value is within the healthy range. It has decreased from 0.05 (Mar 23) to 0.04, marking a decrease of 0.01.
For Asset Turnover Ratio (%), as of Mar 24, the value is 0.84. It has decreased from 0.90 (Mar 23) to 0.84, marking a decrease of 0.06.
For Current Ratio (X), as of Mar 24, the value is 2.08. This value is within the healthy range. It has decreased from 2.09 (Mar 23) to 2.08, marking a decrease of 0.01.
For Quick Ratio (X), as of Mar 24, the value is 1.81. This value is within the healthy range. It has increased from 1.77 (Mar 23) to 1.81, marking an increase of 0.04.
For Inventory Turnover Ratio (X), as of Mar 24, the value is 5.07. This value is within the healthy range. It has decreased from 7.88 (Mar 23) to 5.07, marking a decrease of 2.81.
For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 49.03. This value is within the healthy range. It has decreased from 64.67 (Mar 23) to 49.03, marking a decrease of 15.64.
For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 39.98. This value is within the healthy range. It has decreased from 48.61 (Mar 23) to 39.98, marking a decrease of 8.63.
For Earning Retention Ratio (%), as of Mar 24, the value is 50.97. This value is within the healthy range. It has increased from 35.33 (Mar 23) to 50.97, marking an increase of 15.64.
For Cash Earning Retention Ratio (%), as of Mar 24, the value is 60.02. This value is within the healthy range. It has increased from 51.39 (Mar 23) to 60.02, marking an increase of 8.63.
For Interest Coverage Ratio (X), as of Mar 24, the value is 16.13. This value is within the healthy range. It has increased from 13.33 (Mar 23) to 16.13, marking an increase of 2.80.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 10.04. This value is within the healthy range. It has increased from 6.96 (Mar 23) to 10.04, marking an increase of 3.08.
For Enterprise Value (Cr.), as of Mar 24, the value is 3,661.98. It has increased from 1,567.62 (Mar 23) to 3,661.98, marking an increase of 2,094.36.
For EV / Net Operating Revenue (X), as of Mar 24, the value is 1.57. This value is within the healthy range. It has increased from 0.67 (Mar 23) to 1.57, marking an increase of 0.90.
For EV / EBITDA (X), as of Mar 24, the value is 10.30. This value is within the healthy range. It has increased from 6.56 (Mar 23) to 10.30, marking an increase of 3.74.
For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 1.75. This value is within the healthy range. It has increased from 0.81 (Mar 23) to 1.75, marking an increase of 0.94.
For Retention Ratios (%), as of Mar 24, the value is 50.96. This value is within the healthy range. It has increased from 35.32 (Mar 23) to 50.96, marking an increase of 15.64.
For Price / BV (X), as of Mar 24, the value is 2.24. This value is within the healthy range. It has increased from 1.13 (Mar 23) to 2.24, marking an increase of 1.11.
For Price / Net Operating Revenue (X), as of Mar 24, the value is 1.75. This value is within the healthy range. It has increased from 0.81 (Mar 23) to 1.75, marking an increase of 0.94.
For EarningsYield, as of Mar 24, the value is 0.06. This value is below the healthy minimum of 5. It has decreased from 0.09 (Mar 23) to 0.06, marking a decrease of 0.03.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Balmer Lawrie & Company Ltd as of May 16, 2025 is: 190.34

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of May 16, 2025, Balmer Lawrie & Company Ltd is Overvalued by 16.15% compared to the current share price 227.00

Default values used*: Default value of 15 for Stock P/E is used

Intrinsic Value of Balmer Lawrie & Company Ltd as of May 16, 2025 is: 222.80

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of May 16, 2025, Balmer Lawrie & Company Ltd is Overvalued by 1.85% compared to the current share price 227.00

Default values used*: Default value of 15 for Stock P/E is used

Last 5 Year EPS CAGR: 17.05%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The stock has a high average ROCE of 15.92%, which is a positive sign. The company has higher reserves (1,304.85 cr) compared to borrowings (106.85 cr), indicating strong financial stability. The company has shown consistent growth in sales (1.77 cr) and profit (213.38 cr) over the years.	The stock has a high average Working Capital Days of 34.42, which may not be favorable. The stock has a high average Cash Conversion Cycle of 28.00, which may not be favorable.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Balmer Lawrie & Company Ltd:
1. Net Profit Margin: 8.52%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 13.71% (Industry Average ROCE: 22.55%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 14.36% (Industry Average ROE: 17.78%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 10.04
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 1.81
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 15 (Industry average Stock P/E: 28.43)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0.04
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Balmer Lawrie & Company Ltd. is a Public Limited Listed company incorporated on 18/02/1924 and has its registered office in the State of West Bengal, India. Company's Corporate Identification Number(CIN) is L15492WB1924GOI004835 and registration number is 004835. Currently Company is involved in the business activities of Manufacture of other containers. Company's Total Operating Revenue is Rs. 2318.59 Cr. and Equity Capital is Rs. 171.00 Cr. for the Year ended 31/03/2024.

INDUSTRY	ADDRESS	CONTACT
Diversified	21, Netaji Subhas Road, Kolkata West Bengal 700001	bhavsar.k@balmerlawrie.com http://www.balmerlawrie.com

Management
Name	Position Held
Mr. Adhipnath Palchaudhuri	Chairman & Managing Director
Mr. Saurav Dutta	Director - Finance & CFO
Dr. Vandana Minda Heda	Independent Director
Mr. Rajeev Kumar	Independent Director
Mr. R M Uthayaraja	Director
Mr. Abhijit Ghosh	Director
Mr. Mrityunjay Jha	Government Nominee Director

FAQ

What is the intrinsic value of Balmer Lawrie & Company Ltd?

Balmer Lawrie & Company Ltd's intrinsic value (as of 15 May 2025) is ₹190.34 — 16.15% lower the current market price of 227.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 3,876 Cr. market cap, FY2025-2026 high/low of ₹320/147, reserves of 1,613 Cr, and liabilities of 2,904 Cr.

What is the Market Cap of Balmer Lawrie & Company Ltd?

The Market Cap of Balmer Lawrie & Company Ltd is 3,876 Cr..

What is the current Stock Price of Balmer Lawrie & Company Ltd as on 15 May 2025?

The current stock price of Balmer Lawrie & Company Ltd as on 15 May 2025 is 227.

What is the High / Low of Balmer Lawrie & Company Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of Balmer Lawrie & Company Ltd stocks is ₹320/147.

What is the Stock P/E of Balmer Lawrie & Company Ltd?

The Stock P/E of Balmer Lawrie & Company Ltd is 15.0.

What is the Book Value of Balmer Lawrie & Company Ltd?

The Book Value of Balmer Lawrie & Company Ltd is 104.

What is the Dividend Yield of Balmer Lawrie & Company Ltd?

The Dividend Yield of Balmer Lawrie & Company Ltd is 3.75 %.

What is the ROCE of Balmer Lawrie & Company Ltd?

The ROCE of Balmer Lawrie & Company Ltd is 15.6 %.

What is the ROE of Balmer Lawrie & Company Ltd?

The ROE of Balmer Lawrie & Company Ltd is 14.7 %.

What is the Face Value of Balmer Lawrie & Company Ltd?

The Face Value of Balmer Lawrie & Company Ltd is 10.0.